fluoxetine has been researched along with modafinil in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 10 (55.56) | 29.6817 |
| 2010's | 8 (44.44) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Alelyunas, YW; Bui, K; Empfield, JR; McCarthy, D; Pelosi-Kilby, L; Shen, C; Spreen, RC | 1 |
| Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Antonelli, T; Bebe, BW; Ferraro, L; Fuxe, K; Rambert, FA; Tanganelli, S; Tomasini, MC | 1 |
| Camacho, A; Stein, MB | 1 |
| Fort, P; Frydman, A; Gallopin, T; Luppi, PH; Rambert, FA | 1 |
| Glass, SJ; Hassman, HA; McManus, FC; Ninan, PT | 1 |
| Agnati, L; Antonelli, T; Ferraro, L; Fuxe, K; Tanganelli, S; Tomasini, MC | 1 |
| Eriksson, KS; Wisor, JP | 1 |
| Alessi, C; Aurora, RN; Boehlecke, B; Brown, T; Chesson, AL; Friedman, L; Kapur, VK; Maganti, R; Morgenthaler, TI; Owens, J; Pancer, J; Swick, TJ; Zak, R | 1 |
| Arand, DL; Auger, RR; Brooks, SN; Watson, NF; Wise, MS | 1 |
| Russell, R; Soltanifar, S | 1 |
| Abolfazli, R; Akhondzadeh, S; Ghaleiha, A; Ghanizadeh, A; Golalizadeh, M; Hosseini, M; Raznahan, M; Tabrizi, M | 1 |
| Cha, DS; Kim, RD; Mansur, RB; McIntyre, RS | 1 |
| Endres, M; Gertz, K; Hellmann-Regen, J; Heuser, I; Kronenberg, G; Otte, C; Regen, F; Uhlemann, R | 1 |
4 review(s) available for fluoxetine and modafinil
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Practice parameters for the treatment of narcolepsy and other hypersomnias of central origin.
Topics: Antidepressive Agents, Tricyclic; Benzhydryl Compounds; Cataplexy; Central Nervous System Stimulants; Disorders of Excessive Somnolence; Evidence-Based Medicine; Fluoxetine; Humans; Modafinil; Narcolepsy; Treatment Outcome | 2007 |
Treatment of narcolepsy and other hypersomnias of central origin.
Topics: Antidepressive Agents, Tricyclic; Benzhydryl Compounds; Cataplexy; Central Nervous System Stimulants; Disorders of Excessive Somnolence; Evidence-Based Medicine; Fluoxetine; Humans; Modafinil; Narcolepsy; Randomized Controlled Trials as Topic; Sodium Oxybate | 2007 |
A review of FDA-approved treatment options in bipolar depression.
Topics: Antidepressive Agents; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Benzhydryl Compounds; Benzodiazepines; Bipolar Disorder; Central Nervous System Stimulants; Depressive Disorder; Dibenzothiazepines; Drug Approval; Drug Combinations; Excitatory Amino Acid Antagonists; Fluoxetine; Humans; Isoindoles; Ketamine; Lamotrigine; Lurasidone Hydrochloride; Modafinil; Quetiapine Fumarate; Selective Serotonin Reuptake Inhibitors; Thiazoles; Triazines; United States; United States Food and Drug Administration | 2013 |
2 trial(s) available for fluoxetine and modafinil
| Article | Year |
|---|---|
Adjunctive modafinil at initiation of treatment with a selective serotonin reuptake inhibitor enhances the degree and onset of therapeutic effects in patients with major depressive disorder and fatigue.
Topics: Adolescent; Adult; Aged; Benzhydryl Compounds; Central Nervous System Stimulants; Depressive Disorder, Major; Diagnostic and Statistical Manual of Mental Disorders; Disorders of Excessive Somnolence; Drug Therapy, Combination; Fatigue; Female; Fluoxetine; Humans; Male; Middle Aged; Modafinil; Pilot Projects; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Surveys and Questionnaires | 2004 |
Double-blind randomized parallel-group clinical trial of efficacy of the combination fluoxetine plus modafinil versus fluoxetine plus placebo in the treatment of major depression.
Topics: Adult; Antidepressive Agents, Second-Generation; Benzhydryl Compounds; Central Nervous System Stimulants; Depressive Disorder, Major; Double-Blind Method; Drug Therapy, Combination; Female; Fluoxetine; Humans; Iran; Male; Middle Aged; Modafinil; Personality Inventory; Psychometrics; Young Adult | 2011 |
12 other study(ies) available for fluoxetine and modafinil
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate.
Topics: Central Nervous System Agents; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Solubility | 2010 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Modafinil does not affect serotonin efflux from rat frontal cortex synaptosomes: comparison with known serotonergic drugs.
Topics: Animals; Benzhydryl Compounds; Fenfluramine; Fluoxetine; Frontal Lobe; In Vitro Techniques; Male; Modafinil; Neuroprotective Agents; Paroxetine; Potassium; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Serotonin; Sleep; Synaptic Transmission; Synaptosomes; Tritium | 2001 |
Modafinil for social phobia and amphetamine dependence.
Topics: Amphetamine-Related Disorders; Benzhydryl Compounds; Central Nervous System Stimulants; Comorbidity; Diagnosis, Dual (Psychiatry); Drug Therapy, Combination; Female; Fluoxetine; Humans; Middle Aged; Modafinil; Phobic Disorders; Rehabilitation, Vocational | 2002 |
TetraTab--cognitive enhancement gone wrong.
Topics: Benzhydryl Compounds; Drug Combinations; Fluoxetine; Humans; Modafinil; Nootropic Agents; Tablets | 2003 |
Effect of the wake-promoting agent modafinil on sleep-promoting neurons from the ventrolateral preoptic nucleus: an in vitro pharmacologic study.
Topics: Animals; Benzhydryl Compounds; Carbachol; Cholinergic Agonists; Clonidine; Electrophysiology; Fluoxetine; Histamine; In Vitro Techniques; Modafinil; Neurons; Neuroprotective Agents; Norepinephrine; Phenylephrine; Rats; Rats, Sprague-Dawley; Serotonin; Sleep; Sympathomimetics; Visual Pathways; Wakefulness | 2004 |
Modafinil enhances the increase of extracellular serotonin levels induced by the antidepressant drugs fluoxetine and imipramine: a dual probe microdialysis study in awake rat.
Topics: Animals; Antidepressive Agents; Antidepressive Agents, Tricyclic; Benzhydryl Compounds; Brain; Central Nervous System Stimulants; Depressive Disorder; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Extracellular Fluid; Fluoxetine; Imipramine; Male; Microdialysis; Modafinil; Neural Pathways; Prefrontal Cortex; Raphe Nuclei; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Serotonin; Up-Regulation; Wakefulness | 2005 |
Dopaminergic-adrenergic interactions in the wake promoting mechanism of modafinil.
Topics: Adrenergic Agents; Animals; Benzhydryl Compounds; Benzylamines; Brain; Central Nervous System Stimulants; Dopamine; Dopamine Agonists; Fluoxetine; Male; Mice; Modafinil; Narcolepsy; Neural Pathways; Norepinephrine; Quinpirole; Sleep; Wakefulness | 2005 |
Neuraxial anaesthesia for caesarean section in a patient with narcolepsy and cataplexy.
Topics: Adult; Anesthesia, Epidural; Anesthesia, Obstetrical; Antidepressive Agents, Second-Generation; Benzhydryl Compounds; Cataplexy; Central Nervous System Stimulants; Cesarean Section; Female; Fluoxetine; Humans; Modafinil; Narcolepsy; Obesity, Morbid; Pregnancy | 2010 |
Direct inhibition of retinoic acid catabolism by fluoxetine.
Topics: Animals; Antidepressive Agents, Second-Generation; Benzhydryl Compounds; Cell Line, Tumor; Cell Survival; Cerebral Cortex; Chromatography, High Pressure Liquid; Diazepam; Dose-Response Relationship, Drug; Fluoxetine; Glutamic Acid; Humans; Modafinil; Neurons; Neuroprotective Agents; Rats, Wistar; Receptors, Retinoic Acid; Synaptosomes; Tretinoin | 2015 |